Skip to content

A Clinical study to evaluate the efficacy of a Unani formulation in the management of Urolithiasis

A Clinical study on the management of Urolithiasis with a Unani treatment- An open label single arm study. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057301
Enrollment
40
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter Health Condition 2: N202- Calculus of kidney with calculus of ureter

Interventions

Intervention1: Minerlo-herbal unani formulation and Pharmacopeial syrup, Hajrulyahood(lapis judaicus),Aulthi(Dolichos biflorus),Khar-Khask(Tribulus terrestris),Bhuiamla(Phyllanthus niruri),Namak turb(

Sponsors

Ayurvedic and Unani tibbia college and and hospital karol bagh new delhi-110005
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient between the age of 18-65 years of either sex,Diagnosed cases of Urolithiasis with less than or equal to 10mm size, Patient willing to participate and sign the consent form,Patient willing to discontinue the drugs taking for the treatment of Urolithiasis

Exclusion criteria

Exclusion criteria: Stone size more than 10mm,Stone in the lower pole of kidney and urethra,Patients any anatomical abnormality of urinary tract,Patients with obstruction in urinary passage,Patients with gross hydronephrosis,Patients with pyelonephritis,Patients with diabetes mellitus,Pregnant and lactating women,Renal and hepatic insufficiency and malignancy,Patients unwilling to sign the consent form

Design outcomes

Primary

MeasureTime frame
effect of a mineralo- herbal Unani formulation in reducing the size of renal stone size will be assessed on USG.Timepoint: Baseline, 42nd day

Secondary

MeasureTime frame
Flank pain, dysuria, frequency & nausea/vomiting will be assessed.Timepoint: Baseline, 10th day, 20th day, 30th day & 42nd day

Countries

India

Contacts

Public ContactDr Naseem Akhtar Khan

Ayurvedic and Unani tibbia college and hospital karol bagh new delhi-110005

drkhannaseem.akhtarkhan@gmail.com98100815997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026